Suppr超能文献

罗格列酮在脂多糖诱导的腹膜炎中的作用:大鼠腹膜透析模型

Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.

作者信息

Song Sang Heon, Kwak Ihm Soo, Yang Byeong Yun, Lee Dong Won, Lee Soo Bong, Lee Min Young

机构信息

Department of Internal Medicine, Pusan National University Hospital, Ami-dong, Seo-gu, Busan, Korea.

出版信息

Nephrology (Carlton). 2009 Apr;14(2):155-63. doi: 10.1111/j.1440-1797.2008.01037.x.

Abstract

AIM

The aim of this study was to demonstrate the efficacy of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist, rosiglitazone, in the amelioration or prevention of inflammation including peritoneal fibrosis secondary to the peritonitis in a peritoneal dialysis (PD) model of non-uraemic rats.

METHODS

Thirty male Sprague-Dawley rats were assigned to six groups according to treatment. A 90 min peritoneal equilibrium test, dialysate cellular components, peritoneal thickness and cellularity were assessed on day 21. Additionally, immunohistochemical stains of peritoneal membrane, such as PPAR-gamma, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta1, collagen-1 and monocyte chemoattractant protein-1 were performed.

RESULTS

The dialysate neutrophil count and peritoneal thickness in the high-dose rosiglitazone group was significantly decreased compared to the lipopolysaccharide (LPS)-only group. The peritoneal membrane from the LPS-only group showed marked cellular proliferation in the area of the submesothelial compact zone compared with the PD-only group, the rosiglitazone-only group, and the high-dose rosiglitazone group. The 90 min peritoneal equilibrium test (PET) results showed no statistical difference among the six groups excluding dialysate-to-plasma urea ratio. The number of PPAR-gamma expressing cells and the expression of TGF-beta1 were decreased in the high-dose rosiglitazone group compared to the LPS-only group. There were no differences in the expression of VEGF and collagen-1 among the six groups. Interestingly, the number of PPAR-gamma-positive cells was correlated with expression of VEGF, TGF-beta1, collagen-1 and monocyte chemoattractant protein-1 irrespective of the study group.

CONCLUSION

The results of this study showed that rosiglitazone ameliorated peritoneal inflammation induced by LPS and reduced the TGF-beta1 expression in the peritoneal membranes.

摘要

目的

本研究旨在证明过氧化物酶体增殖物激活受体(PPAR)-γ激动剂罗格列酮在改善或预防非尿毒症大鼠腹膜透析(PD)模型中包括腹膜炎继发腹膜纤维化在内的炎症方面的疗效。

方法

30只雄性Sprague-Dawley大鼠按治疗方法分为6组。在第21天评估90分钟腹膜平衡试验、透析液细胞成分、腹膜厚度和细胞密度。此外,对腹膜进行免疫组织化学染色,检测PPAR-γ、血管内皮生长因子(VEGF)、转化生长因子(TGF)-β1、胶原蛋白-1和单核细胞趋化蛋白-1等。

结果

与仅用脂多糖(LPS)组相比,高剂量罗格列酮组的透析液中性粒细胞计数和腹膜厚度显著降低。与仅行PD组、仅用罗格列酮组和高剂量罗格列酮组相比,仅用LPS组的腹膜间皮下致密区出现明显的细胞增殖。90分钟腹膜平衡试验(PET)结果显示,除透析液与血浆尿素比值外,6组之间无统计学差异。与仅用LPS组相比,高剂量罗格列酮组PPAR-γ表达细胞数量和TGF-β1表达降低。6组之间VEGF和胶原蛋白-1的表达无差异。有趣的是,无论研究组如何,PPAR-γ阳性细胞数量与VEGF、TGF-β1、胶原蛋白-1和单核细胞趋化蛋白-1的表达均相关。

结论

本研究结果表明,罗格列酮可改善LPS诱导的腹膜炎症,并降低腹膜中TGF-β1的表达。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验